FB2026_03 , released September 17, 2026
Human Disease Model Report: inflammatory bowel disease
Open Close
General Information
Name
inflammatory bowel disease
FlyBase ID
FBhh0000917
Disease Ontology Term
Parent Disease
OMIM
Overview

Inflammatory bowel disease (IBD) is a term for two conditions (Crohn disease and ulcerative colitis) that are characterized by chronic inflammation of the gastrointestinal tract. Development of IBD has both genetic and environmental components, including the intestinal microbiome, defects in barrier function, and dysregulated host responses to microbial stimulation. Single gene defects impact a subset of patients with inflammatory bowel disease, particularly those with early-onset disease. The OMIM phenotypic series for this disease defines several implicated genes and many susceptibility loci; see the link below.

[updated Nov. 2018 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: inflammatory bowel disease
OMIM report
Symptoms and phenotype

Inflammatory bowel disease is characterized by a chronic relapsing intestinal inflammation. IBD is subdivided into Crohn disease and ulcerative colitis phenotypes. Crohn disease and ulcerative colitis have a combined prevalence of 200 to 300 per 100,000 in the United States. Crohn disease may involve any part of the gastrointestinal tract, but most frequently the terminal ileum and colon. Bowel inflammation is transmural and discontinuous; it may contain granulomas or be associated with intestinal or perianal fistulas. In contrast, in ulcerative colitis, the inflammation is continuous and limited to rectal and colonic mucosal layers; fistulas and granulomas are not observed. In approximately 10% of cases confined to the rectum and colon, definitive classification of Crohn disease or ulcerative colitis cannot be made and are designated 'indeterminate colitis.' Both diseases include extraintestinal inflammation of the skin, eyes, or joints. [from MIM:266600; 2018.11.09]

Genetics

Inflammatory bowel disease is most often a polygenic disorder with contributions from the intestinal microbiome, defects in barrier function, and dysregulated host responses to microbial stimulation. There is, however, increasing recognition of single gene defects that underlie a subset of patients with inflammatory bowel disease, particularly those with early-onset disease (Kelsen and Sullivan, 2017; pubmed:28755025).

There is strong evidence from twin studies, familial risk data, and segregation analysis that susceptibility to inflammatory bowel disease, especially Crohn disease, is genetic (Yang and Rotter, 1994; Duerr, 1996, pubmed:23282455). [from MIM:266600; 2018.11.09]

Cellular phenotype and pathology
Molecular information

Crohn disease and ulcerative colitis are commonly classified as autoimmune diseases. The prevalence of inflammatory bowel disease is increased in individuals with other autoimmune diseases. [from MIM:266600; 2018.11.09]

External links
Disease synonyms
Crohn disease
IBD
Search term: intestinal barrier dysfunction
ulcerative colitis
Ortholog Information
Human gene(s) in FlyBase
    Other mammalian ortholog(s) used
      D. melanogaster Gene Information (0)
      Other Genes Used: Viral, Bacterial, Synthetic (0)
        Summary of Physical Interactions (0 groups)
        Alleles Reported to Model Human Disease (Disease Ontology) (0 alleles)
        Alleles Representing Disease-Implicated Variants
        Genetic Tools, Stocks and Reagents
        Sources of Stocks
        Contact lab of origin for a reagent not available from a public stock center.
        Bloomington Stock Center Disease Page
        Related mammalian, viral, bacterial, or synthetic transgenes
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila transgenes
        Allele
        Transgene
        Publicly Available Stocks
        RNAi constructs available
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila classical alleles
        Allele
        Allele class
        Mutagen
        Publicly Available Stocks
        References (17)